Reports
Peripherally inserted central catheters (PICC) are commonly known as percutaneous indwelling central catheters or PICC line. PICC lines are often used in antibiotic therapy, chemotherapy, or total parenteral nutrition or for administration of drugs that should not be given peripherally. PICC line is inserted in the body percutaneously at peripheral site and extended up to superior vena cava. It is an alternative to central venous catheter, which is inserted through major veins such as jugular or femoral. Generally, PICC line is appropriate for patients who have undergone more than two weeks of treatment. These catheters are well sustained by neonates, with dwell time of two to three weeks. However, dwell time varies case to case. There could be risk of complications such as phlebitis, bleeding, and catheter occlusion due to holding of PICC for more than a month. Strict infection control procedures should be followed before insertion of PICC line to reduce the risk of infection.
Several global manufacturers plan to introduce innovative and technologically advanced products in the market. These innovations present numerous opportunities in the global neonatal peripherally inserted central venous catheters market, offering easy use of vascular access devices associated with increasing patient safety. Vygon S.A. provides a range of advanced polyurethane PICC catheters such as Premicath injectable catheters, Nutriline, and Premistar. Pregnancy complications such as multiple births are associated with an increased risk of preterm delivery, low birth weight, and other associated high-risk morbidities. This increases demand for NICU services. Newborn infections and birth asphyxia account for over 80% of all global neonatal deaths. This has created a need of early diagnosis and appropriate treatment in hospitals, which in turn has increased NICU admissions. These factors contribute to the growth of the global neonatal peripherally inserted central venous catheters market. Safer and advanced catheter insertion systems and availability of trained technicians due to rise in adoption of PICC line are expected to fuel the growth of the global market. The cost of vascular access device and its maintenance forms a crucial economic factor in the long-term management of complications. Neonatal intensive care is extremely expensive, causing financial burden on both the family and the health care system.
Increase in Incidence of Neonatal Illnesses
According to the World Health Organization, every year, nearly 41% of all under-five child deaths are among newborn infants, babies in their first 28 days of life or the neonatal period. The risk of death of a baby in the first four weeks of life is nearly 15 times greater than any other time before his or her one year of birth. About 8.2 million under-five child deaths per year, about 3.3 million occur during the neonatal period in the first four weeks of life.
Rise in Cases of Preterm Birth due to Premature Rupture of Membrane
Premature rupture of membrane (PROM) is rupture of the membrane (amniotic sac) before labor begins. If PROM occurs before 37 weeks of pregnancy, it is called preterm premature rupture of membrane (PPROM). PROM occurs in about 8% to 10% of all pregnancies. The incidence of premature rupture of membrane ranges from about 5% to 10% of all deliveries.
The global neonatal peripherally inserted central venous catheters market is highly consolidated owing to the presence of small number of key players. Leading players operating in the global neonatal peripherally inserted central venous catheters market include:
Global Neonatal Peripherally Inserted Central Venous Catheters Market, Product Type
Global Neonatal Peripherally Inserted Central Venous Catheters Market, By Design Type
Global Neonatal Peripherally Inserted Central Venous Catheters Market, By Application
Global Neonatal Peripherally Inserted Central Venous Catheters Market, by End-user
Global Neonatal Peripherally Inserted Central Venous Catheters Market, by Region
N/A